⌘K
Loading ticker…
Contineum Therapeutics, Inc. Class A Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a 3-month relative strength percentile of 48 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 66. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.9%, relative volume 15.80×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
48 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
CTNM is in a stage 2 uptrend, week 1. Currently in a 88-day base; basing ADR 6.9% (broad 7.1%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 9.0% / 13.2%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
CTNM is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $12M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $12M |
| VXFVanguard Extended Market ETF | 0.00% | $4M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CTNM Jan avg: -4.21% median: -4.21% win: 50% σ: 40.97% n: 2 2024-04-08 → 2026-05-29 | CTNM Feb avg: -10.26% median: -10.26% win: 50% σ: 25.22% n: 2 2024-04-08 → 2026-05-29 | CTNM Mar avg: -7.86% median: -7.86% win: 0% σ: 9.91% n: 2 2024-04-08 → 2026-05-29 | CTNM Apr avg: -13.88% median: -1.84% win: 33% σ: 23.64% n: 3 2024-04-08 → 2026-05-29 | CTNM May avg: -2.51% median: -1.80% win: 33% σ: 8.11% n: 3 2024-04-08 → 2026-05-29 | CTNM Jun avg: 11.71% median: 11.71% win: 100% σ: 4.58% n: 2 2024-04-08 → 2026-05-29 (current) | CTNM Jul avg: 31.26% median: 31.26% win: 100% σ: 24.54% n: 2 2024-04-08 → 2026-05-29 | CTNM Aug avg: 37.14% median: 37.14% win: 50% σ: 56.54% n: 2 2024-04-08 → 2026-05-29 | CTNM Sep avg: 5.32% median: 5.32% win: 50% σ: 10.07% n: 2 2024-04-08 → 2026-05-29 | CTNM Oct avg: -9.37% median: -9.37% win: 0% σ: 4.34% n: 2 2024-04-08 → 2026-05-29 | CTNM Nov avg: -5.25% median: -5.25% win: 50% σ: 8.19% n: 2 2024-04-08 → 2026-05-29 | CTNM Dec avg: 0.75% median: 0.75% win: 50% σ: 3.53% n: 2 2024-04-08 → 2026-05-29 |